Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis

ABSTRACT Background Autoimmune encephalitis (AE) in children represents a group of immune‐mediated brain disorders with mild to severe neurological complications that are mostly recoverable with appropriate timely therapy. AE is complicated to diagnose and manage, particularly in Latin America, where access to diagnostic tests and treatments is limited. This study aimed to compare clinical outcomes in pediatric patients with AE who tested positive for autoantibodies versus those who tested negative. Methods We conducted a retrospective cohort, secondary analysis of the multicenter study REAL LABIC, including data from multiple countries in Latin America. We divided patients with AE into two groups based on their autoimmune antibody status: those with positive antibodies (Ab+) and those with negative antibodies (Ab−). We compared presentation, treatment responses, and clinical outcomes between the two groups. Results A total of 37 (59.7%) were Ab+, while 25 (40.3%) were Ab−. Neurological symptoms at admission were similar between groups, except for behavioral disturbances, which were more frequent in Ab+ patients (89% vs. 60%, p = 0.012) and required more aggressive treatment, including second‐line therapies, intensive care unit (ICU) admission, and mechanical ventilation. Conclusions Children with antibody‐positive AE in Latin America had a more severe disease course and required more intensive therapeutic interventions than antibody‐negative patients. These findings underscore the importance of timely diagnosis and equitable access to advanced diagnostic and therapeutic resources in the region.

Authors

Institutions

Publication Details

Journal
Annals of the Child Neurology Society
Published
2026-11-15
DOI
https://doi.org/10.1002/cns3.70097
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis

Jesús Domínguez-Rojas, Álvaro Coronado Muñoz, Verónica María Alaña Peña, Carmen Rojas Julián et al.
Annals of the Child Neurology Society
Autoimmune Neurological Disorders and Treatments
article

Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis

Jesús Domínguez-Rojas, Álvaro Coronado Muñoz, Verónica María Alaña Peña, Carmen Rojas Julián, José Domingo Barrientos-Guerra, Christoper Alexander Alarcon-Ruiz, Daniel Agustín Godoy, Karen Perales Caballero, Maricela García-Arellano, Ruth Vela-Sosa, Cíntia Johnston, Miguel A. Vences, Juan David Roa, Pablo Vásquez‐Hoyos, Cibele Lopes Queiroz de Lima, Mercedes A. Suarez‐Loro
article en

Abstract

ABSTRACT Background Autoimmune encephalitis (AE) in children represents a group of immune‐mediated brain disorders with mild to severe neurological complications that are mostly recoverable with appropriate timely therapy. AE is complicated to diagnose and manage, particularly in Latin America, where access to diagnostic tests and treatments is limited. This study aimed to compare clinical outcomes in pediatric patients with AE who tested positive for autoantibodies versus those who tested negative. Methods We conducted a retrospective cohort, secondary analysis of the multicenter study REAL LABIC, including data from multiple countries in Latin America. We divided patients with AE into two groups based on their autoimmune antibody status: those with positive antibodies (Ab+) and those with negative antibodies (Ab−). We compared presentation, treatment responses, and clinical outcomes between the two groups. Results A total of 37 (59.7%) were Ab+, while 25 (40.3%) were Ab−. Neurological symptoms at admission were similar between groups, except for behavioral disturbances, which were more frequent in Ab+ patients (89% vs. 60%, p = 0.012) and required more aggressive treatment, including second‐line therapies, intensive care unit (ICU) admission, and mechanical ventilation. Conclusions Children with antibody‐positive AE in Latin America had a more severe disease course and required more intensive therapeutic interventions than antibody‐negative patients. These findings underscore the importance of timely diagnosis and equitable access to advanced diagnostic and therapeutic resources in the region.

Annals of the Child Neurology Society
Albert Einstein College of Medicine (US), Montefiore Medical Center (US), Universidade de São Paulo (BR), Universidad El Bosque (CO), Universidad Peruana Cayetano Heredia (PE), Universidad de San Martín de Porres (PE), Universidad Científica del Sur (PE), Hospital General San Juan de Dios (GT), Universidad Nacional de Colombia (CO), Instituto Nacional de Salud del Niño (PE), EsSALUD (PE), Instituto Nacional de Salud del Niño-San Borja (PE), Hospital Nacional Edgardo Rebagliati Martins (PE), Meditech Foundation (CO)
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon